Skip to main content

Table 1 Characteristics of healthy controls and patients with severe MMCAI

From: Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction

 

Healthy controls (n = 50)

Patients (n = 50)

p-value

Gender female – n (%)

13 (26.0 %)

17 (34 %)

0.51

Age (years) - median (p 25–75)

57 (50–63)

60 (51–69)

0.11

TIMP-1 (ng/mL) - median (p 25–75)

226 (213–241)

261 (199–387)

0.02

MMP-9 (ng/mL) - median (p 25–75)

498 (350–735)

749 (488–1200)

0.001

MMP-10 (pg/mL) - median (p 25–75)

466 (288–614)

1027 (556–1409)

<0.001

  1. MMP = matrix metalloproteinase; TIMP = tissue inhibitor of matrix metalloproteinases
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us